Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate Cancer

Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate Cancer

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Genitourinary Cancer - Volume 14, Issue 2, April 2016, Pages e233-e236

Edmund C.P. Chedgy, Matti Annala, Kevin Beja, Evan W. Warner, Martin E. Gleave, Kim N. Chi, Alexander W. Wyatt,